Found: 342
Select item for more details and to access through your institution.
A New Era in the Management of Multiple Myeloma.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 7, p. 800
- By:
- Publication type:
- Article
Monoclonal gammopathy in the setting of Pyoderma gangrenosum.
- Published in:
- Archives of Dermatological Research, 2024, v. 316, n. 6, p. 1, doi. 10.1007/s00403-024-03098-7
- By:
- Publication type:
- Article
Deep learning‐based virtual noncalcium imaging in multiple myeloma using dual‐energy CT.
- Published in:
- Medical Physics, 2022, v. 49, n. 10, p. 6346, doi. 10.1002/mp.15934
- By:
- Publication type:
- Article
In vivo assessment of glutamine anaplerosis into the TCA cycle in human pre-malignant and malignant clonal plasma cells.
- Published in:
- Cancer & Metabolism, 2020, v. 8, n. 1, p. 1, doi. 10.1186/s40170-020-00235-4
- By:
- Publication type:
- Article
Phase II study of novel CXCR2 agonist and Plerixafor for rapid stem cell mobilization in patients with multiple myeloma.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01152-1
- By:
- Publication type:
- Article
Real-life sensitivity of flow cytometry minimal residual disease assessment for plasma cell neoplasms.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Long term responders in frontline multiple myeloma—exception vs expectation of the modern era.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Performance of newer myeloma staging systems in a contemporary, large patient cohort.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01076-w
- By:
- Publication type:
- Article
Mode of progression in smoldering multiple myeloma: a study of 406 patients.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00980-5
- By:
- Publication type:
- Article
Outcomes of t(11;14) light chain (AL) amyloidosis after autologous stem cell transplantation: benchmark for new therapies.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00945-0
- By:
- Publication type:
- Article
Long-term outcomes of allogeneic stem cell transplant in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00900-z
- By:
- Publication type:
- Article
Cutaneous and systemic amyloidoses.
- Published in:
- 2002
- By:
- Publication type:
- Editorial
Candidate genes of Waldenström's macroglobulinemia: current evidence and research.
- Published in:
- Application of Clinical Genetics, 2013, v. 6, p. 33, doi. 10.2147/TACG.S42690
- By:
- Publication type:
- Article
Treatment of Multiple Myeloma and the Role of Melphalan in the Era of Modern Therapies—Current Research and Clinical Approaches.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 9, p. 1841, doi. 10.3390/jcm10091841
- By:
- Publication type:
- Article
RWD-derived response in multiple myeloma.
- Published in:
- PLoS ONE, 2023, v. 18, n. 5, p. 1, doi. 10.1371/journal.pone.0285125
- By:
- Publication type:
- Article
Impact of belantamab mafodotin‐induced ocular toxicity on outcomes of patients with advanced multiple myeloma.
- Published in:
- British Journal of Haematology, 2022, v. 199, n. 1, p. 95, doi. 10.1111/bjh.18298
- By:
- Publication type:
- Article
Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID‐19 pandemic.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 3, p. 346, doi. 10.1111/bjh.16898
- By:
- Publication type:
- Article
Frequent methylation of the tumour suppressor miR‐1258 targeting PDL1: implication in multiple myeloma‐specific cytotoxicity and prognostification.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 2, p. 249, doi. 10.1111/bjh.16517
- By:
- Publication type:
- Article
Mass cytometry identifies expansion of double positive and exhausted T cell subsets in the tumour microenvironment of patients with POEMS syndrome.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 1, p. 79, doi. 10.1111/bjh.16522
- By:
- Publication type:
- Article
Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes.
- Published in:
- British Journal of Haematology, 2020, v. 188, n. 3, p. 394, doi. 10.1111/bjh.16168
- By:
- Publication type:
- Article
Clinical features, laboratory characteristics and outcomes of patients with renal versus cardiac light chain amyloidosis.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 4, p. 701, doi. 10.1111/bjh.15832
- By:
- Publication type:
- Article
Substratification of patients with newly diagnosed standard‐risk multiple myeloma.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 2, p. 254, doi. 10.1111/bjh.15800
- By:
- Publication type:
- Article
Phase 2 study of all‐oral ixazomib, cyclophosphamide and low‐dose dexamethasone for relapsed/refractory multiple myeloma.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 4, p. 536, doi. 10.1111/bjh.15679
- By:
- Publication type:
- Article
Impact of duration of induction therapy on survival in newly diagnosed multiple myeloma patients undergoing upfront autologous stem cell transplantation.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 1, p. 71, doi. 10.1111/bjh.15244
- By:
- Publication type:
- Article
Natural history of amyloidosis isolated to fat and bone marrow aspirate.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 1, p. 170, doi. 10.1111/bjh.14205
- By:
- Publication type:
- Article
Dexamethasone, rituximab and cyclophosphamide for relapsed and/or refractory and treatment-naïve patients with Waldenstrom macroglobulinemia.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 1, p. 98, doi. 10.1111/bjh.14826
- By:
- Publication type:
- Article
Elevation of serum lactate dehydrogenase in AL amyloidosis reflects tissue damage and is an adverse prognostic marker in patients not eligible for stem cell transplantation.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 6, p. 888, doi. 10.1111/bjh.14830
- By:
- Publication type:
- Article
Impact of concomitant dexamethasone dosing schedule on bortezomib-induced peripheral neuropathy in multiple myeloma.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 5, p. 756, doi. 10.1111/bjh.14754
- By:
- Publication type:
- Article
Management of adverse events associated with ixazomib plus lenalidomide/dexamethasone in relapsed/refractory multiple myeloma.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 4, p. 571, doi. 10.1111/bjh.14733
- By:
- Publication type:
- Article
A Phase Ib Study of the combination of the Aurora Kinase Inhibitor Alisertib ( MLN8237) and Bortezomib in Relapsed Multiple Myeloma.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 2, p. 323, doi. 10.1111/bjh.13765
- By:
- Publication type:
- Article
Quantification of clonal circulating plasma cells in relapsed multiple myeloma.
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 4, p. 500, doi. 10.1111/bjh.13067
- By:
- Publication type:
- Article
AT-101 downregulates BCL2 and MCL1 and potentiates the cytotoxic effects of lenalidomide and dexamethasone in preclinical models of multiple myeloma and Waldenström macroglobulinaemia.
- Published in:
- British Journal of Haematology, 2014, v. 164, n. 3, p. 352, doi. 10.1111/bjh.12633
- By:
- Publication type:
- Article
Akt inhibitor MK2206 selectively targets CLL B-cell receptor induced cytokines, mobilizes lymphocytes and synergizes with bendamustine to induce CLL apoptosis.
- Published in:
- British Journal of Haematology, 2014, v. 164, n. 1, p. 146, doi. 10.1111/bjh.12564
- By:
- Publication type:
- Article
Novel pedigree analysis implicates DNA repair and chromatin remodeling in multiple myeloma risk.
- Published in:
- PLoS Genetics, 2018, v. 14, n. 2, p. 1, doi. 10.1371/journal.pgen.1007111
- By:
- Publication type:
- Article
Increased complexity of t(11;14) rearrangements in plasma cell neoplasms compared with mantle cell lymphoma.
- Published in:
- Genes, Chromosomes & Cancer, 2021, v. 60, n. 10, p. 678, doi. 10.1002/gcc.22977
- By:
- Publication type:
- Article
Three‐dimensional telomere profiling predicts risk of progression in smoldering multiple myeloma.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 8, p. 1532, doi. 10.1002/ajh.27364
- By:
- Publication type:
- Article
High‐risk multiple myeloma: Redefining genetic, clinical, and functional high‐risk disease in the era of molecular medicine and immunotherapy.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 8, p. 1560, doi. 10.1002/ajh.27327
- By:
- Publication type:
- Article
A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL).
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 8, p. 1277, doi. 10.1002/ajh.26990
- By:
- Publication type:
- Article
Prevention of infections including vaccination strategies in multiple myeloma.
- Published in:
- American Journal of Hematology, 2023, v. 98, p. S46, doi. 10.1002/ajh.26766
- By:
- Publication type:
- Article
Dynamic monitoring of minimal residual disease in newly‐diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. E61, doi. 10.1002/ajh.26810
- By:
- Publication type:
- Article
Survival trends in young patients with Waldenström macroglobulinemia: Over five decades of experience.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 432, doi. 10.1002/ajh.26807
- By:
- Publication type:
- Article
Proposed risk‐scoring model for estimating the prognostic impact of 1q gain in patients with newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. 251, doi. 10.1002/ajh.26774
- By:
- Publication type:
- Article
Overexpression of the energy metabolism transcriptome within clonal plasma cells is associated with the pathogenesis and outcomes of patients with multiple myeloma.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 7, p. 895, doi. 10.1002/ajh.26577
- By:
- Publication type:
- Article
Current approaches to management of newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2022, v. 97, p. S3, doi. 10.1002/ajh.26512
- By:
- Publication type:
- Article
Multicentric Castleman disease: A single center experience of treatment with a focus on autologous stem cell transplantation.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. 401, doi. 10.1002/ajh.26466
- By:
- Publication type:
- Article
Characteristics and risk factors for thrombosis in POEMS syndrome: A retrospective evaluation of 230 patients.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 2, p. 209, doi. 10.1002/ajh.26422
- By:
- Publication type:
- Article
Chimeric antigen receptor T‐cells, bispecific antibodies, and antibody‐drug conjugates for multiple myeloma: An update.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 1, p. 99, doi. 10.1002/ajh.26379
- By:
- Publication type:
- Article
Venetoclax for the treatment of multiple myeloma: Outcomes outside of clinical trials.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 9, p. 1131, doi. 10.1002/ajh.26269
- By:
- Publication type:
- Article
Current approaches to management of high‐risk multiple myeloma.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 7, p. 854, doi. 10.1002/ajh.26161
- By:
- Publication type:
- Article
The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significance.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 7, p. 846, doi. 10.1002/ajh.26155
- By:
- Publication type:
- Article